Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
DSM-Firmenich AGDSMFF 57 EV-to-EBIT is 32.12 as of Jul. 26, 2026, which is 56% above its 10-year median of 20.54. GuruFocus rates DSMFF with a GF Score™ of 57/100 and a GF Value™ of $89.09 (Fairly Valued). The stock has 8 warning signs investors should review. Among 1,241 Chemicals companies, DSM-Firmenich AG ranks worse than 74.13% on this metric.
DSM-Firmenich AG (OTCPK:DSMFF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
DSM-Firmenich AG's Enterprise Value for the quarter that ended in Dec. 2025 was $24,438 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DSM-Firmenich AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $837 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG EV-to-EBIT Related Terms
DSM-Firmenich AG EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for DSM-Firmenich AG's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, DSM-Firmenich AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DSM-Firmenich AG EV-to-EBIT vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, DSM-Firmenich AG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where DSM-Firmenich AG's EV-to-EBIT falls into.
DSM-Firmenich AG's current Enterprise Value is $26,903 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. DSM-Firmenich AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $837 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DSM-Firmenich AG (DSMFF) has a EV-to-EBIT of 32.12 as of Jul. 26, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on DSM-Firmenich AG and its competitors. This is 56% above median its historical median of 20.54. According to the industry distribution chart, DSM-Firmenich AG ranks #920 out of 1241 companies in the Chemicals industry, placing it in the top 74.1%.
Is DSM-Firmenich AG's EV-to-EBIT too high?
DSM-Firmenich AG's current EV-to-EBIT of 32.12 is 56% above median its 10-year median of 20.54. The Chemicals industry median EV-to-EBIT is 17.14. DSM-Firmenich AG's value of 32.12 is 87.4% above this industry median. Based on the distribution chart, DSM-Firmenich AG ranks #920 out of 1241 companies in the Chemicals industry, which is below the industry midpoint. Overall, DSM-Firmenich AG has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DSM-Firmenich AG's EV-to-EBIT compare to LIN and SHW?
According to the Chemicals industry distribution chart, DSM-Firmenich AG ranks #920 out of 1241 companies for EV-to-EBIT. This places DSM-Firmenich AG in the lower half of its industry. The industry median EV-to-EBIT is 17.14. DSM-Firmenich AG's value of 32.12 is 87.4% above this benchmark. While the company's 10-year median is 20.54 vs. the industry median of 17.14, DSM-Firmenich AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Chemicals company?
The median EV-to-EBIT among Chemicals companies is 17.14, based on 1,241 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DSM-Firmenich AG's current EV-to-EBIT of 32.12 is 87.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on DSM-Firmenich AG and its competitors. For the Chemicals industry, the median EV-to-EBIT is 17.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DSM-Firmenich AG's current EV-to-EBIT is 32.12, which is 56% above median its own 10-year median of 20.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DSM-Firmenich AG stock overvalued right now?
Based on GuruFocus' analysis, DSM-Firmenich AG (DSMFF) is currently considered Fairly Valued. The stock's GF Value™ is $89.09, compared to a current price of $91.31 — trading 2.5% above its estimated fair value. The current EV-to-EBIT is 32.12, which is 56% above median its 10-year median of 20.54 and 87.4% above the Chemicals industry median of 17.14. DSM-Firmenich AG's overall GF Score™ is 57/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For DSM-Firmenich AG (DSMFF), the current EV-to-EBIT is 32.12 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DSM-Firmenich AG (DSMFF) Overvalued in 2026?
Based on GuruFocus' analysis, DSM-Firmenich AG stock appears to be overvalued.
The current stock price of $91.31 is trading 2.5% above its estimated GF Value™ of $89.09.
GuruFocus considers DSM-Firmenich AG to be Fairly Valued.
Key valuation signals for DSMFF:
EV-to-EBIT: 32.12 (56% above median its 10-year median of 20.54)
GF Value™: $89.09 vs. price of $91.31 (2.5% above fair value)
Industry Position: 87.4% above the Chemicals median (#920 of 1241)
No single metric tells the full story. See the DSMFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
57GF Score
Get the complete analysis for DSMFF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DSMFF has been successfully added to your 
